期刊文献+

选择性食管动脉灌注化疗治疗68例中晚期中下段食管癌 被引量:2

68 Cases with Advanced Carcinoma in Medial or Lower Esophagus Treated by Selective Esophageal Arterial Infusion
下载PDF
导出
摘要 目的 观察用选择性动脉灌注化疗治疗中晚期中下段食管癌的疗效 ,了解临床分期和影像分型对疗效的影响。方法 对 6 8例中晚期中下段食管癌行选择性食管动脉灌注化疗 ,并随访 6个月。结果 患者的总缓解率及中、晚期缓解率分别为 48 5 % ,6 1 9%和 2 6 9% ,中晚期疗效相差显著 (P <0 .0 5 )。影像Ⅰ Ⅳ型的缓解率分别为 42 3 % ,5 2 0 % ,6 4 3 %及 0 % ,型间相差不显著 (P >0 .0 5 )。结论 动脉灌注化疗对中晚期中下段食管癌疗效可靠 ;临床分期可以直接影响患者的疗效 ;但影像分型对疗效无影响。 Objective To observe the response of advanced carcinoma in medial or lower esophagus treated by selective arterial infusion and to analyse the treatment influence from clinical stage and imageological classification Method 68 patients with advanced carcinoma in their medial or lower esophagi were treated by selective esophageal arterial infusion and were followed up for six months Result The total, the TNMⅡ、Ⅲ stage teams' and the TNMⅣ stage team's remission rates were 48.5%, 61.9%, and 26.9% repectively There was a significant difference between the two teams' responses ( P <0.05) Imageological Ⅰ Ⅳ types' remission rates were 42.3%, 52.0%, 64.3% and 0% respectively There was no difference between every two types ( P >0.05%) Conclusion (1) Selcctive arterial infusion was an effective therapy to treat advanced carcinoma in medial or lower esophagus (2) Clinical stages might directly influence treatment effect (3) Imageological classification might have nothing to do with treatment effect
机构地区 解放军第
出处 《临床军医杂志》 CAS 2000年第3期30-31,共2页 Clinical Journal of Medical Officers
关键词 动脉灌注化疗 食管肿瘤 selective arterial infusion esophageal tumor
  • 相关文献

参考文献2

共引文献3

同被引文献19

  • 1马富.逆行性奇静脉造影的应用解剖学[J].解剖学杂志,1986(2):130-131. 被引量:3
  • 2王志良,樊青霞,王瑞林,李天晓,韩新卫.选择性食管动脉灌注化疗治疗不能手术的食管癌[J].中国肿瘤临床,1996,23(5):370-371. 被引量:3
  • 3祁建 马兆荣 等.胃贲门附近静脉的外科解剖[J].临床解剖学杂志,1987,5:263-266.
  • 4Ymlo M, Inoue M, Shiozaki H. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer [J]. Ann Thorac Cardiovasc Surg, 2002. 8(3):123-130.
  • 5Refaely Y. Krasna MJ. Multimodality therapy for esophageal cancer[J]. Surg Clin North Am. 2002, 82(4)729-746.
  • 6Chan AC, Lee DW, Griffith JF, et al. The clinical efficacy of ncoadjuvant chemotherapy in squamous esophageal cancer:a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Huororacil[J]. Ann Surg Oncol, 2002, 9(7):617-624.
  • 7Kelscn DP, Ginsberg R, Pajak TF. et al. Chemotherapy followed by surgery compared with surgery alone for localized csophageal canccr[J]. N Engl J Med, 1998. 339(27):1979-1984.
  • 8UrschelJD,Vasan H, Blewett CJ. A meta-analysis of randomized controlled uials that compared neoadiuvant chemotherapy and surgery to alone for respectable esophagcal cancer [J]. Am J Surg.2002,183 (3):274 - 279.
  • 9Bedard EL, hlculet RI, Malthaner RA, et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal squamous carcinoma [J]. Cancer. 2001.91 (12):2423 -2430.
  • 10Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus:A japan clinical Onculogy group study -JCOG9204[J].J Clin Oncol, 2003, 21 (24):4592 - 4596.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部